Tuberculosis cases in the Czech Republic in 2009
Authors:
Jiří Homolka 1; František Krejbich 1; Jiří Holub 2
Authors place of work:
Univerzita Karlova v Praze, 1. lékařská fakulta, I. klinika tuberkulózy a respiračních nemocí VFN
1; Ústav zdravotnických informací a statistiky České republiky
2
Published in the journal:
Čas. Lék. čes. 2011; 150: 330-333
Category:
Original Article
Summary
Background.
The number of notified tuberculosis cases in the Czech Republic in 2009 was lower than in 2008. 710 new tuberculosis cases and relapses were reported.
Material and methods.
598 cases were pulmonary tuberculosis and from them 439 were proved pulmonary tuberculosis cases. In 2009 235 smear-positive cases of pulmonary tuberculosis were diagnosed.
Results.
The incidence of tuberculosis was 6.8/100000 inhabitants in 2009. The percentage of tuberculosis cases diagnosed in foreign-born persons living in the Czech Republic increased from 14.2% in 2003 to 19.2% in 2009.
Conclusions.
Next targets of tuberculosis control in the Czech Republic must be an active case-finding in the high-risk groups and monitoring of latent tuberculosis infection.
Key words:
tuberculosis, epidemiology, treatment.
Zdroje
1. Trnka L, Madaras AT, Krejbich F, Zatloukal P. Tuberculosis control and surveillance in changing health reform in the Czech Republic. Med Arh 1999; 53 (3 Suppl 1): 11–12.
2. Homolka J, Krejbich F, Mazánková V. Tuberkulóza v České republice v roce 2003. Čas Lék čes 2004; 143(9): 594–597.
3. Homolka J, Krejbich F, Holub J. Tuberkulóza v České republice v roce 2007. Čas Lék čes 2009; 148(5): 197–200.
4. WHO Report 2008, Global Tuberculosis Control surveilance, planing, financing, Avenue Appia, 1211 Geneva, 2, s. 1–2.
5. Homolka J, Krejbich F. Tuberkulóza u cizinců v České republice v letech 2003–2006. Čas Lék čes 2008; 147(3): 155–158.
6. Homolka J, Krejbich F, Mazánková V. Tuberkulóza v České republice v roce 2003. Čas Lék čes 2004; 143(9): 594–597.
7. WHO Regional Office for Europe: Strategy to control tuberculosis in the WHO European Region, Copenhagen 2000, s. 1–54.
8. Pedersen JT, Pallisgaard G. Tuberculosis in low prevalence countries. Back to the future? Ugeskr Laeger 1995; 157(49): 6859–6863.
9. European Centre for Disease Prevention and Control/WHO Regional Office for Europe: Tuberculosis surveillance in Europe 2007. Stockholm: European Centre for Disease Prevention and Control, 2009.
10. Veen J, Raviglione MC, Rieder HL. Standardised treatment outcome monitoring in Europe. Recomendation of WHO and IUATLD Working Group. Third European Workshop on Tuberculosis Control in Low Prevalence Countries, Noordwijk, Netherlands, 15–20 June 1997. Eur Respir J 1998; 12: 1–54.
11. European Centre for Disease Prevention and Control/WHO Regional Office for Europe: Tuberculosis surveillance in Europe 2008. Stockholm: European Centre for Disease Prevention and Control, 2010.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Variability of the deep femoral venous system
- The disease caused by Clostridium difficile in geriatric patients
- Idiopathic inflammatory bowel disease – prediction and treatment
- KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma